Physician profile
Taylor Yoder
NPI 1083180590
$1,282.47
in general payments reported to CMS, 2019-2025
24 companies · $94.39 in 2025
The $94.39 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $387 · 2023: $166 · 2024: $348 · 2025: $94.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $282.85 | 2023-2024 | Vtama |
| Abbvie INC. | $173.28 | 2021-2025 | |
| Leo Pharma INC. | $141.62 | 2022-2024 | Adbry |
| Janssen Scientific Affairs, LLC | $123.66 | 2022 | |
| Channel Medsystems, INC. | $61.14 | 2022 | |
| Vyne Pharmaceuticals INC. | $52.79 | 2021 | |
| Almirall LLC | $49.19 | 2021-2023 | Seysara |
| Lilly USA, LLC | $42.12 | 2021-2024 | Olumiant |
| Optumhealth Care Solutions, LLC | $40.65 | 2023-2024 | Zyno Solutions, Vivify Health Care Team Portal, Vivify Health Care Team Portal 001 |
| Therapeuticsmd, INC. | $32.25 | 2021 | |
| Organon LLC | $29.94 | 2021-2023 | Nexplanon |
| Agile Therapeutics, INC. | $29.09 | 2022 | |
| Avion Pharmaceuticals | $28.77 | 2022 | |
| Exeltis, USA INC. | $28.69 | 2021-2024 | Slynd |
| Mylan Pharmaceuticals INC. | $23.73 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $23.08 | 2025 | Zurzuvae |
| Genentech USA, INC. | $18.26 | 2025 | Xolair |
| Qiagen, LLC | $16.98 | 2024 | |
| Astellas Pharma US INC | $15.51 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $15.24 | 2021 | |
| Boston Scientific Corporation | $14.53 | 2022 | |
| Cipher Pharmaceuticals US LLC | $14.40 | 2025 | Natroba, Spinosad |
| Mayne Pharma Commercial LLC | $13.20 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.